The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase 2/3 randomized, controlled study of CTX-009 in combination with paclitaxel versus paclitaxel alone in adult patients with unresectable advanced, metastatic or recurrent biliary tract cancers who have received one prior systemic chemotherapy regimen.
 
Marilyn Fontaine
Employment - Black Diamond Therapeutics; Boston Biomedical; Compass Therapeutics
Stock and Other Ownership Interests - Black Diamond Therapeutics; Compass Therapeutics
Travel, Accommodations, Expenses - Boston Biomedical; Compass Therapeutics
 
Sarah Pilgrim
No Relationships to Disclose
 
Thomas Schuetz
Employment - Compass Therapeutics
Leadership - Compass Therapeutics
Stock and Other Ownership Interests - Compass Therapeutics
Patents, Royalties, Other Intellectual Property - Compass Therapeutics patents assigned to Compass.
Travel, Accommodations, Expenses - Compass Therapeutics